“proteostasis-therapeutics” Archives

in
Entry Author Date Location
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More 03/29/19 National
Analysts: Proteostasis Data Are No Boost vs. Vertex in Cystic Fibrosis 03/25/19 Boston
15 For ’19: Key Clinical Data to Watch For Next Year (Part 2) 12/18/18 National
Vertex Hits Again in CF as First Three-Drug Combo Succeeds in Phase 3 11/27/18 Boston
Vertex Hums Along as AbbVie Snatches Up a Rival’s CF Drugs for $45M 10/25/18 Boston
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive’s End 10/19/18 National
Vertex CF Competitor Proteostasis Falters, Galapagos Up Next 06/07/18 Boston
Bio Roundup: CMS Backs Cancer Tests, Right to Try Passes, AbbVie Sinks 03/23/18 National
Many Biotechs Need Inside IPO Help, But Selecta Is An Extreme Case 06/22/16 Boston
Tech Megatransfer: Merck Pays Harvard $20M For “Accelerated” Cancer Drugs 03/21/16 Boston
East Coast Biotech Roundup: Ribon, Syndax, Aldeyra & More 03/03/16 Boston
Syndax Cuts Price But Bags $53M in Second IPO Try 03/02/16 Boston
East Coast Biotech Roundup: Scangos, CRISPR, Yumanity, Synlogic & More 02/11/16 New York
Proteostasis Cuts Price But Heads to Nasdaq After $50M IPO 02/11/16 Boston
Tech Mogul, Patriots Owner Lavish $73M On Dana-Farber Startup 01/07/16 Boston
Proteostasis Therapeutics Obtains $10,000,000 New Funding 09/16/15 Boston
Proteostasis Therapeutics Lands $37,000,000 Series B Funding 09/09/15 Boston
Moderna’s Third mRNA Startup, Elpidera, Sets Sights on Rare Diseases 05/12/15 Boston
East Coast Biotech Roundup: Intercept, Idera, Inotek, & More 11/07/14 Boston
Proteostasis, Astellas Join up on Genetic Disease Drugs 11/04/14 Boston
Proteostasis Therapeutics Garners $5,000,000 New Financing Round 10/08/14 Boston
Sold For Parts, Accelerator Grad Allozyne Reaches End of the Line 09/18/14 Seattle
East Coast Biotech Roundup: ASH, Proteostasis, Retrophin, & More 12/13/13 Boston
Proteostasis, Biogen Team up on Protein Homeostasis Drugs 12/09/13 Boston
Forma Strikes $200M Deal With Celgene to Discover Cancer Drugs 04/29/13 Boston
Cleave Biosciences Nabs $42M, Veteran Execs, to Chase Personalized Cancer Therapies 10/11/11 San Francisco
Harvard Accelerator Program, Proving Its Mettle with Startups and Pharma Partnerships, Looks to Raise Big New Fund 08/11/11 Boston
VC Investments in Boston Companies Soar to 1999 Levels ($1B+); Here Are the Top 10 Deals from the 2nd Quarter 07/21/11 Boston
Excelimmune Grabs $10.5M, Aveo Gets $15M In J&J Deal, Myriant Aims for $125M IPO, & More Boston-Area Deals News 06/01/11 Boston
Page 1 of 2 next page »